Company For Clinical Research

Home > Therapeutic Focus > CID


Leader in SLE, RA and Crohn diseases

Our close professional relations with the KIL in the field of rheumatology drove Resbiomed to become a leader in clinical studies on the Balkans

Phase I – Phase Ia clinical studies involving over 25 sites.